Stern DM - Search Results

1

Receptor for advanced glycation end products on human synovial fibroblasts: role in the pathogenesis of dialysis-related amyloidosis.

Hou FF, Jiang JP, Guo JQ, Wang GB, Zhang X, Stern DM, Schmidt AM, Owen WF Jr. Hou FF, et al. Among authors: stern dm. J Am Soc Nephrol. 2002 May;13(5):1296-1306. doi: 10.1681/ASN.V1351296. J Am Soc Nephrol. 2002. PMID: 11961018

2

Receptor for advanced glycation endproducts (RAGE) and the complications of diabetes.

Stern DM, Yan SD, Yan SF, Schmidt AM. Stern DM, et al. Ageing Res Rev. 2002 Feb;1(1):1-15. doi: 10.1016/s0047-6374(01)00366-9. Ageing Res Rev. 2002. PMID: 12039445 Review.

3

Expression of advanced glycation end products and their cellular receptor RAGE in diabetic nephropathy and nondiabetic renal disease.

Tanji N, Markowitz GS, Fu C, Kislinger T, Taguchi A, Pischetsrieder M, Stern D, Schmidt AM, D'Agati VD. Tanji N, et al. J Am Soc Nephrol. 2000 Sep;11(9):1656-1666. doi: 10.1681/ASN.V1191656. J Am Soc Nephrol. 2000. PMID: 10966490

4

Receptor for advanced glycation endproducts: a multiligand receptor magnifying cell stress in diverse pathologic settings.

Stern D, Yan SD, Yan SF, Schmidt AM. Stern D, et al. Adv Drug Deliv Rev. 2002 Dec 7;54(12):1615-25. doi: 10.1016/s0169-409x(02)00160-6. Adv Drug Deliv Rev. 2002. PMID: 12453678 Review.

5

What's the RAGE? The receptor for advanced glycation end products (RAGE) and the dark side of glucose.

Yan SD, Stern D, Schmidt AM. Yan SD, et al. Eur J Clin Invest. 1997 Mar;27(3):179-81. doi: 10.1046/j.1365-2362.1996.00072.x. Eur J Clin Invest. 1997. PMID: 9088851 Review. No abstract available.

6

Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis.

Schmidt AM, Yan SD, Wautier JL, Stern D. Schmidt AM, et al. Circ Res. 1999 Mar 19;84(5):489-97. doi: 10.1161/01.res.84.5.489. Circ Res. 1999. PMID: 10082470 Review.

7

Receptor for advanced glycation endproducts (RAGE) and vascular inflammation: insights into the pathogenesis of macrovascular complications in diabetes.

Wendt T, Bucciarelli L, Qu W, Lu Y, Yan SF, Stern DM, Schmidt AM. Wendt T, et al. Among authors: stern dm. Curr Atheroscler Rep. 2002 May;4(3):228-37. doi: 10.1007/s11883-002-0024-4. Curr Atheroscler Rep. 2002. PMID: 11931721 Review.

8

RAGE drives the development of glomerulosclerosis and implicates podocyte activation in the pathogenesis of diabetic nephropathy.

Wendt TM, Tanji N, Guo J, Kislinger TR, Qu W, Lu Y, Bucciarelli LG, Rong LL, Moser B, Markowitz GS, Stein G, Bierhaus A, Liliensiek B, Arnold B, Nawroth PP, Stern DM, D'Agati VD, Schmidt AM. Wendt TM, et al. Among authors: stern dm. Am J Pathol. 2003 Apr;162(4):1123-37. doi: 10.1016/S0002-9440(10)63909-0. Am J Pathol. 2003. PMID: 12651605 Free PMC article.

9

Central role of RAGE-dependent neointimal expansion in arterial restenosis.

Sakaguchi T, Yan SF, Yan SD, Belov D, Rong LL, Sousa M, Andrassy M, Marso SP, Duda S, Arnold B, Liliensiek B, Nawroth PP, Stern DM, Schmidt AM, Naka Y. Sakaguchi T, et al. Among authors: stern dm. J Clin Invest. 2003 Apr;111(7):959-72. doi: 10.1172/JCI17115. J Clin Invest. 2003. PMID: 12671045 Free PMC article.

10

Blockade of receptor for advanced glycation endproducts: a new target for therapeutic intervention in diabetic complications and inflammatory disorders.

Hudson BI, Bucciarelli LG, Wendt T, Sakaguchi T, Lalla E, Qu W, Lu Y, Lee L, Stern DM, Naka Y, Ramasamy R, Yan SD, Yan SF, D'Agati V, Schmidt AM. Hudson BI, et al. Among authors: stern dm. Arch Biochem Biophys. 2003 Nov 1;419(1):80-8. doi: 10.1016/j.abb.2003.08.030. Arch Biochem Biophys. 2003. PMID: 14568011 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

265 results

Search Page

Filters